Psychosocial Treatment of Depression in Parkinson's Disease
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Boston |
| State: |
|
Massachusetts |
| Zip Code: |
|
02114 |
| Conditions: |
|
Major Depressive Disorder - Parkinson's Disease |
| Purpose: |
|
The purpose of the study is to examine the effects of a form of talk therapy called
cognitive behavior therapy (CBT) in the treatment of major depression in individuals with
Parkinson's disease (PD).
|
| Study Summary: |
|
CBT is a specific type of treatment that has been shown to be as helpful in treating
depression as medications for depression. CBT focuses on thoughts, feelings, and behaviors.
It focuses on the here and now, rather than the past. CBT offers concrete strategies and
skills for coping with depression, PD, and other life problems. Previous research leads us
to believe that this type of therapy may help people with PD cope with their depression.
|
| Criteria: |
|
Inclusion Criteria:
In addition to the DSM-IV diagnostic criteria for major depressive disorder, the following
conditions must be met for patient eligibility:
- Written informed consent.
- Subjects with a primary diagnosis of PD who also currently meet DSM-IV criteria for
MDD
- Subjects must be stable on their anti-Parkinson treatment, as defined by no
medication changes over the past 6 weeks
- Subjects may be taking an antidepressant as long as they have had a stable dose for
up to 6 weeks and do not alter the dosage during the course of the study
- Men or women 40-80 years of age
- HAMD-17 scores > 14 at screen visit
- Score of 25 or greater on the Mini-Mental Status Examination
- Willing to come to MGH for screening and study participation
Exclusion Criteria:
Patients meeting any of the following criteria are to be excluded from the study:
- Subjects who, in the investigator's judgment, pose a current, serious suicidal or
homicidal risk
- Patients who would not be appropriate for a delayed CBT control due to the severity
of their depression based on clinical judgment as well as HAMD-17 scores > 28
- The following DSM-IV diagnoses: 1) substance use disorders, including alcohol
dependence, active within the last 3 months; 2) schizophrenia; 3) delusional
disorder; 4) psychotic disorders not elsewhere classified; 5) bipolar disorder; 6)
MDD with psychotic features
- Subjects who meet DSM-IV criteria for dementia
- Severe, unstable concurrent medical conditions (determined by his/her physician) that
are likely to require hospitalization within six months from study entry (e.g., a
patient with severe congestive heart failure who has a history of recent hospital
admissions)
- Subjects may not be receiving a psychosocial intervention that is specific for
depression; psychosocial interventions not specific for depression (e.g., couples
counseling) and established for three or more months before screen visit are allowed
|
| NCT ID: |
|
NCT00853346 |
| Primary Contact: |
|
Principal Investigator
Amy Farabaugh, PhD
Massachusetts General Hospital
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Boston, Massachusetts 02114
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|